Glenmede Trust’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-827
Closed -$10K 1236
2020
Q3
$10K Buy
827
+144
+21% +$1.85K ﹤0.01% 1869
2020
Q2
$9K Buy
683
+7
+1% +$102 ﹤0.01% 1897
2020
Q1
$14K Hold
676
﹤0.01% 2251
2019
Q4
$14K Buy
676
+206
+44% +$4.22K ﹤0.01% 2251
2019
Q3
$9 Buy
470
+77
+20% +$1.41K ﹤0.01% 2382
2019
Q2
$6 Hold
393
﹤0.01% 2550
2019
Q1
$7 Sell
393
-467
-54% -$8.92K ﹤0.01% 2488
2018
Q4
$14 Buy
+860
New +$15.8K ﹤0.01% 2131

Other funds holding OSG

Glenmede Trust's OSG Position: Q4 2020 in Review

Glenmede Trust sold out of Octave Specialty Group (OSG) in Q4 2020, closing a stake of 827 shares — an estimated $10K sold.

Glenmede Trust first reported a position in OSG in Q4 2018 and held it in 8 quarters. The position peaked at $14K in Q1 2020. 142 funds tracked by Wall St. Rank hold OSG as of Q4 2020.

  • Glenmede Trust reported no remaining Octave Specialty Group position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 827 Octave Specialty Group shares in Q4 2020, an estimated $10K.
  • Glenmede Trust first reported a position in Octave Specialty Group in Q4 2018 and held it in 8 quarters.
  • Glenmede Trust's Octave Specialty Group position peaked at $14K in Q1 2020.
  • 142 funds tracked by Wall St. Rank held Octave Specialty Group as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.